FDA approval paves the way for pioneer EPFL-spinoff GTX Medical

FDA approval paves the way for pioneer EPFL-spinoff GTX Medical

12.6.2020 – is developing therapies to accelerate recovery and quality of life of people with spinal cord injury. The startup received the US Food and Drug Administration (FDA) Breakthrough Device Designation – an important milestone that paves the way for future development.

Congratulations go to Prof. Grégoire CourtineVincent Delattre and their team at GTX medical for this achievement.

Learn more with this article published by Startupticker.ch